Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

K Brian Halak

Affiliations

  • Director at Alimera Sciences Inc (ALIM), 2019-06-21
  • Large Shareholder at Alliqua Biomedical Inc. (ADYX), 2019-05-13
  • Director at Dicerna Pharmaceuticals Inc (DRNA), 2018-11-06
  • Large Shareholder at Obalon Therapeutics Inc (OBLN), 2018-08-27
  • Large Shareholder at Bionano Genomics Inc (BNGO), 2018-08-27
  • Large Shareholder at Ocera Therapeutics Inc. (OCRX), 2017-12-13
  • Large Shareholder at Tobira Therapeutics Inc. (TBRA), 2016-11-04
  • Large Shareholder at Evoke Pharma Inc (EVOK), 2016-05-27
  • Large Shareholder at Syndax Pharmaceuticals Inc (SNDX), 2016-03-08
  • Large Shareholder at Glaukos Corp (GKOS), 2015-07-01
  • Large Shareholder at Atyr Pharma Inc (LIFE), 2015-05-13
  • Large Shareholder at Esperion Therapeutics Inc. (ESPR), 2015-03-24
  • Large Shareholder at Neothetics Inc. (NEOT), 2014-12-10
  • Large Shareholder at Durata Therapeutics Inc. (DRTX), 2014-11-18
  • Large Shareholder at Atara Biotherapeutics Inc. (ATRA), 2014-10-21
  • Large Shareholder at Veracyte Inc. (VCYT), 2014-09-12
  • Large Shareholder at Otonomy Inc. (OTIC), 2014-08-18
  • Large Shareholder at Marinus Pharmaceuticals Inc (MRNS), 2014-07-31
  • Large Shareholder at Aldeyra Therapeutics Inc. (ALDX), 2014-05-01
  • Large Shareholder at Cadence Pharmaceuticals Inc (CADX), 2014-03-21
  • Large Shareholder at Achaogen Inc (AKAO), 2014-03-17
  • Large Shareholder at Tandem Diabetes Care Inc (TNDM), 2013-11-19
  • Large Shareholder at Clovis Oncology Inc. (CLVS), 2013-06-05
  • Large Shareholder at Achillion Pharmaceuticals Inc (ACHN), 2013-01-18
  • Large Shareholder at Celator Pharmaceuticals Inc (NONE), 2013-01-15
  • Large Shareholder at Orexigen Therapeutics Inc. (OREX), 2011-12-22
  • Large Shareholder at Zogenix Inc. (ZGNX), 2011-09-20
  • Director at Vanda Pharmaceuticals Inc. (VNDA), 2010-03-30
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
OCRX $6.03 7,333 Large Shareholder 7,333 2013-07-15 Filing
OCRX $6.03 988,285 Large Shareholder 988,285 2013-07-15 Filing
OCRX $6.03 331,873 Large Shareholder 1,897,336 2013-07-15 Filing
OCRX $6.03 7,333 Large Shareholder 7,333 2013-07-15 Filing
OCRX $6.03 988,285 Large Shareholder 988,285 2013-07-15 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
DRNA $14.16 11 Director 19,150 2018-11-06 Filing
DRNA $14.16 1,489 Director 2,586,535 2018-11-06 Filing
DRNA $13.18 761 Director 19,161 2018-11-06 Filing
DRNA $13.18 102,067 Director 2,588,024 2018-11-06 Filing
DRNA $12.98 295 Director 19,922 2018-11-05 Filing